Global Depot Medroxyprogesterone Injection Market Was Valued at USD 800 million in 2021

According to Precision Business Insights (PBI), the Depot Medroxyprogesterone Injection Market is expected to be worth USD 830 million in 2022, growing at a 4.0% CAGR from 2022 to 2028. Global Depot Medroxyprogesterone Injection Market is segmented into the following types: By Type (Prescriptions & Generic Prescriptions), By End User (Hospital, Pharmacy, & Others), By Application (Contraceptive, Hormone Replacement Therapy, Treatment of Endometriosis, and Other), and Geography (North America, Europe, Asia Pacific, Latin America, and MEA) Forecast to 2028. Key players' profiles in the Depot Medroxyprogesterone Injection market report are Pfizer Inc. and Fangtong Pharma. Co. Ltd, Gador S.A., Sigma-Aldrich Co. LLC., Teva Pharmaceutical Industries Ltd., Greenstone LLC, Serum Internation Ltd., West-Coast Pharmaceutical, Arrow Pharma Group, and Zuche Pharmaceuticals Pvt. Ltd. The prevalence of contraceptive use among women of reproductive age (15-49 years) drives the Depot Medroxyprogesterone injection market. Drug controllers continually approve new generics and brands and make them available in pharmacies. Depot medroxyprogesterone acetate has also been found to minimize endometrial and ovarian cancer, as well as to prevent pregnancy and control medical disorders associated with women's menstrual cycles, as well as to relieve endometriosis pain.

View Detailed Report Description at https://precisionbusinessinsights.com/market-reports/depot-medroxyprogesterone-injection-market/

Contraceptive Application Segment Dominates the Depot Medroxyprogesterone Injection Market
The contraceptive Application segment is expected to account for a larger revenue share in the global depot medroxyprogesterone injection market with a larger value share. It is projected to grow at a 4.1% CAGR between 2022 and 2028. DMPA is a long-acting feminine contraceptive medication. Each injection works for at least 12 weeks (+/- 5 days) to inhibit ovulation and offer contraception. It's safe to use in women who've been appropriately counseled about the risk of monthly irregularities and the possibility of a delayed return to total fertility.

Europe Depot Medroxyprogesterone Injection Market
Europe is expected to hold a significant market share in the global depot medroxyprogesterone injection market in the forecast period. It is projected to grow at a CAGR of 3.8% in the coming years. In the European region, injectable hormonal contraceptives are a popular choice of birth control, used by millions of women to prevent pregnancy or delay pregnancy. The number of key players present in the European region and government initiatives to control the birth rate drive the depot medroxyprogesterone injection market in the European region.

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players.
Global Depot Medroxyprogesterone Injection market further reveals that the key players are increasingly adopting strategies such as the launch of newer products, product launches, and long-term alliances to improve market revenue share and gain significant geographic presence across the region. For instance, In July 2017, the Indian government introduced an injectable contraceptive, depot medroxyprogesterone acetate (DMPA), into the public health system. The contraceptive would be made available for free through Mission Parivar Vikas, which seeks to improve family planning services in 145 high-focus districts.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=52615

Detailed Segmentation
Depot Medroxyprogesterone Injection Market is segmented based on type, end-user, application, and geography.
Based on the type, the market is segmented into the following:
• Prescriptions
• Generic Prescriptions

Based on the end-user, the market is segmented into the following:
• Hospital
• Pharmacy
• Others

Based on the application, the market is segmented into the following:
• Contraceptive
• Hormone Replacement Therapy
• Treatment of Endometriosis
• Other

Based on the geography, the market is segmented into the following:
• North America
• Europe
• The Asia Pacific
• Latin America
• MEA

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.